that is not what I said at all.
I said Radient is dead and MacLellan is no longer doing ANYTHING with RXPC. Nobody is leaving RXPC, nobody is joining RXPC, there is no merger or takeover, this company does not and will not operate.
The UNI Agreement was cancelled because there is no SEC filing saying the fee was paid, but the GCDx agreement was paid because there is no SEC filing saying it wasn't? Fine, whatever. None of that matters when the last patent expires on June 3rd 2014. All active agreements terminate on that date, and any kind of exclusivity or confidentiality clauses terminate with the agreement(s). In six weeks, anyone can manufacture, market, and sell the test without paying RXPC another penny. That will officially be the end of RXPC. They have no assets left when their last DR-70 patent expires.
As for the patent on CIT -- that won't expire for a while, but RXPC wrote off CIT as worthless. It is not an asset, according to the company. They would know, I think.
Pity that the MJ rumor was debunked -- that was the only catalyst here. Personally, I found the MJ rumor to be every bit as absurd as the merger rumor, but the pennystock traders showed some interest in the MJ rumor -- they are showing zero interest in the merger rumor, wouldn't you agree?
